Quantcast

Latest Chiron Stories

2014-04-23 23:11:45

New technology from Okuma, Tsugami, Bridgeport, Chiron, Trumpf and leading suppliers of related tooling, accessories, and software will be displayed and demonstrated during this two-day event. Windsor, Conn. (PRWEB) April 23, 2014 Hegman Machinery, LLC, a Morris Group, Inc. company, will hold an Open House and Technology Show at its Maple Grove, Minn. facility on May 21-22, 2014. The regional machine tool distributor will display and demonstrate new technology from Okuma, Tsugami,...

2014-03-28 08:26:48

SAN DIEGO, March 28, 2014 /PRNewswire/ -- aTyr Pharma ("aTyr"), a rare disease biotherapeutics enterprise, announced today the appointment of Ed Penhoet, Ph.D., to the Company's board of directors (BOD). Dr. Penhoet, who co-founded Chiron, is an accomplished scientist and biotech pioneer. He has served on the Independent Citizens Oversight Committee (ICOC) for the California Institute of Regenerative Medicine (CIRM) and was recently appointed to President Obama's Council of...

2013-08-17 23:04:27

Dr. James Hollis has done it again and he will be making an appearance in Lafayette, LA to speak on relationships. Asheville, NC (PRWEB) August 17, 2013 Houston-based Jungian Analyst, Dr. James Hollis, has done it again and "HAUNTINGS: Dispelling the Ghosts Who Run Our Lives" (Chiron 2013), his 14th book, has just recently hit the shelves. Dr. Hollis is coming to Lafayette on August 23 & 24 and will appear at St. Barnabas Episcopal Church – Commons Room – 400 Camellia...

2010-04-05 04:20:00

BOSTON, April 5 /PRNewswire/ -- Monster scorpions. Bulging muscles. Passionate kisses. The clash begins this week -- Clash of the Titans that is. As throngs of moviegoers exit theatres nationwide, they'll wonder "what now?" Forget finding Zeus-like inspiration in boring suburbia or Saturday soccer practice... these fans clearly need a handbook to satisfy Godly needs. With the Hollywood machine buzzing at full-tilt, it's clear the Greek gods are all the rage -- just like ancient times!...

2010-02-22 07:19:00

CAMBRIDGE, Mass., Feb. 22 /PRNewswire/ -- Novartis announced that Menveo® (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by the US Food and Drug Administration (FDA) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people 11 to 55 years of age(1). To view the multimedia assets...

2008-09-18 06:00:19

Reportlinker.com announces that a new market research report related to the Infectious diseases industry is available in its catalogue. World Human Vaccines Market http://www.reportlinker.com/p092575/World-Human-Vaccines-Market.html This report analyzes the worldwide markets for Human Vaccines in Millions of US$. The major product segments analyzed are Prophylactic Vaccines (Pediatric Prophylactic Vaccines, & Adult Prophylactic Vaccines), and Therapeutic Vaccines. The report...

2008-05-06 09:01:22

New Phase III data for Menveo(R) (MenACWY-CRM) show that the vaccine produced a greater immune response against meningococcal serogroups A, C, W-135 and Y in adolescents 11-18 years of age compared to Menactra(R). Infection with any of these four vaccine-preventable serogroups can lead to bacterial meningitis, an infection of the membrane around the brain and spinal cord, or sepsis, a serious infection of the blood stream. Results of this first head-to-head trial of Menveo compared to...

2006-03-16 09:50:00

CHICAGO (Reuters) - Chiron Corp. on Thursday said it is recalling and withdrawing its measles, mumps and rubella vaccine, MORUPAR, from Italian and developing world markets because it may be associated with a higher rate of adverse side effects than other such vaccines. The adverse events on which the recall and withdrawal are based are within a range of those commonly associated with vaccines, such as fever, allergic reactions and swelling of the glands, Chiron said. As a result of the...

2006-02-23 09:33:31

CHICAGO (Reuters) - Third Wave Technologies Inc. on Thursday said it reached an agreement with Chiron Corp. and Bayer Corp. to dismiss its lawsuit against Chiron and Bayer over patents related to hepatitis C virus, or HCV. Terms of the agreement were not disclosed. Madison, Wisconsin-based Third Wave said no licenses were granted or taken under the agreement and no payment was made to any of the companies. It said it has now resolved all of its patent-related lawsuits, with the...

2005-08-31 09:00:00

NEW YORK (Reuters) - Chiron Corp., which last year suspended U.S. sales of its flu vaccine because of contamination problems at its plant in England, on Wednesday said it hopes to supply the vaccine in the 2005-2006 flu season following a favorable inspection of the plant by U.S. regulators. The U.S.-based company's manufacturing license for its Fluvirin vaccine was withdrawn last October because of contamination problems at the factory in Liverpool, depriving the United States of almost half...


Latest Chiron Reference Libraries

10_903a6f8a6523778ac3ab9861ddac6b1f2
2004-10-19 04:45:44

Ophiuchus (serpent bearer) Constellation -- Location: Equatorial, visible in both Hemispheres; Coordinates: Right Ascension: 17h; Declination: 0; Source: Greek Mythology The constellation Ophiuchus seems to be a figure of a man entwined with two snakes, one in each hand. The constellation is an ancient one, but most often associated with Asclepius, the son of Apollo and Coronis. Asclepius was regarded as the founder of medicine, having learned the healing arts from both his father...

More Articles (1 articles) »
Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related